UniProt ID | VEGFD_HUMAN | |
---|---|---|
UniProt AC | O43915 | |
Protein Name | Vascular endothelial growth factor D {ECO:0000312|HGNC:HGNC:3708} | |
Gene Name | VEGFD {ECO:0000312|HGNC:HGNC:3708} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 354 | |
Subcellular Localization | Secreted. | |
Protein Description | Growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors.. | |
Protein Sequence | MYREWVVVNVFMMLYVQLVQGSSNEHGPVKRSSQSTLERSEQQIRAASSLEELLRITHSEDWKLWRCRLRLKSFTSMDSRSASHRSTRFAATFYDIETLKVIDEEWQRTQCSPRETCVEVASELGKSTNTFFKPPCVNVFRCGGCCNEESLICMNTSTSYISKQLFEISVPLTSVPELVPVKVANHTGCKCLPTAPRHPYSIIRRSIQIPEEDRCSHSKKLCPIDMLWDSNKCKCVLQEENPLAGTEDHSHLQEPALCGPHMMFDEDRCECVCKTPCPKDLIQHPKNCSCFECKESLETCCQKHKLFHPDTCSCEDRCPFHTRPCASGKTACAKHCRFPKEKRAAQGPHSRKNP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
155 | N-linked_Glycosylation | EESLICMNTSTSYIS CCCEEEEECCCHHHH | 26.85 | 21148085 | |
185 | N-linked_Glycosylation | LVPVKVANHTGCKCL CEEEEECCCCCCCCC | 35.92 | 21148085 | |
187 | Phosphorylation | PVKVANHTGCKCLPT EEEECCCCCCCCCCC | 44.04 | 30266825 | |
287 | N-linked_Glycosylation | DLIQHPKNCSCFECK HHHCCCCCCCCHHCH | 27.64 | UniProtKB CARBOHYD |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of VEGFD_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VEGFD_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VEGFD_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VGFR2_HUMAN | KDR | physical | 9435229 | |
UBR4_HUMAN | UBR4 | physical | 26186194 | |
ZER1_HUMAN | ZER1 | physical | 26186194 | |
ADAM9_HUMAN | ADAM9 | physical | 26186194 | |
BIRC6_HUMAN | BIRC6 | physical | 26186194 | |
KCMF1_HUMAN | KCMF1 | physical | 26186194 | |
TBB8_HUMAN | TUBB8 | physical | 26186194 | |
MOCS3_HUMAN | MOCS3 | physical | 26186194 | |
OAF_HUMAN | OAF | physical | 26186194 | |
ADAM9_HUMAN | ADAM9 | physical | 28514442 | |
UBR4_HUMAN | UBR4 | physical | 28514442 | |
BIRC6_HUMAN | BIRC6 | physical | 28514442 | |
KCMF1_HUMAN | KCMF1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Structural determinants of vascular endothelial growth factor-D -receptor binding and specificity."; Leppanen V.M., Jeltsch M., Anisimov A., Tvorogov D., Aho K.,Kalkkinen N., Toivanen P., Yla-Herttuala S., Ballmer-Hofer K.,Alitalo K.; Blood 117:1507-1515(2011). Cited for: X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 92-195 OF MUTANT ALA-117,FUNCTION, SUBUNIT, GLYCOSYLATION AT ASN-155 AND ASN-185, AND DISULFIDEBONDS. |